Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants

Journal of Clinical Psychopharmacology

Volumn 34, Issue 2, 2014, Pages 226-229

  Şahingöz, Mine ^a   Yuksel, Goksen ^b   Karsidag, Cagatay ^b   Uguz, Faruk ^a   Sonmez, Erdem Onder ^a   Annagur, Bilge Burcak ^c   Annagur, Ali ^c  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

Author keywords

Antidepressants; Birth weight; Pregnancy; Preterm birth

Indexed keywords

CITALOPRAM; FLUOXETINE; SERTRALINE;

ADULT; ARTICLE; DELIVERY; DEVELOPING COUNTRY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BIRTH WEIGHT; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84896405441     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000077     Document Type: Article

References (30)

1. Uguz F, Gezginc K, Kayhan F, et al. Is pregnancy associated with mood and anxiety disorder? A cross-sectional study. Gen Hosp Psychiatry. 2010;32: 213-215.
2. Felice E, Saliba J, Grech V, et al. Antenatal psychiatric morbidity in Maltase women. Gen Hosp Psychiatry. 2007;29: 501-505.
3. Borri C, Mauri M, Oppo A, et al. Axis I psychopathology and functional impairment at the third month of pregnancy: results from the Perinatal Depression-Research and Screening Unit (PND-ReScU) Study. J Clin Psychiatry. 2008;69: 1617-1624.
4. Andersson L, Sundström-Poromaa I, Wulff M, et al. Depression and anxiety disorder during pregnancy and six months postpartum: a follow-up study. Acta Obstet Gynecol. 2006;85: 937-944.
5. Andersson L, Sundström-Poromaa I, Bixo M, et al. Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol. 2003;189: 148-154.
6. Surkan PJ, Kennedy CE, Hurley KM, et al. Maternal depression and early childhood growth in developing countries: systematic review and meta-analysis. Bull World Health Organ. 2011;287: 607-615.
7. Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67: 1012-1024.
8. Alder J, Fink N, Bitzer J, et al. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A review of the literature. J Matern Fetal Neonatal Med. 2007;20: 189-209.
9. Uguz F, Gezginc K, Kayhan F, et al. Is hyperemesis gravidarum associated with mood, anxiety and personality disorders? A case-control study. Gen Hosp Psychiatry. 2012;34: 398-402.
10. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198: 194.e1-194.e5.
11. Koren G, Nordeng H. Antidepressant use during pregnancy: the benefit-risk ratio. Am J Obstet Gynecol. 2012;207: 157-163.
12. Udechuku A, Nguyen T, Hill R, et al. Antidepressants in pregnancy: a systematic review. Aust N Z J Psychiatry. 2010;44: 978-996.
13. Lewis AJ, Galbally M, Opie G, et al. Neonatal growth outcomes at birth an done month postpartum following in utero exposure to antidepressant medication. Aust N Z J Psychiatry. 2010;44: 482-487.
14. Ellfolk M, Malm H. Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). Reprod Toxicol. 2010;30: 249-260.
15. Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63: 898-906.
16. Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry. 2006;67: 1280-1284.
17. Nordeng H, van Gelder MM, Spigset O, et al. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol. 2012;32: 186-194.
18. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166: 557-566.
19. Lattimore KA, Donn SM, Kaciroti N, et al. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol. 2005;25: 595-604.
20. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, DC: American Psychiatric Press; 1997.
21. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, Welfare Publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976: 218-222.
22. Ramsey PS, Goldenberg RL. Obstetric management of prematurity. In: Martin RJ, Fanaroff AA, Walsh MC, eds. Fanaroff and Martin's Neonatal-Perinatal Medicine. 8th ed. Philadelphia, PA: Mosby Elsevier; 2006: 271-306.
23. Davalos DB, Yadon CA, Tregellas HC. Untreated prenatal maternal depression and the potential risks of offspring: a review. Arch Womens Ment Health. 2012;15: 1-14.
24. Leitner Y, Fattal-Valevski A, Geva R, et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol. 2007;22: 580-587.
25. Tan TY, Yeo GS. Intrauterine growth restriction. Curr Opin Obstet Gynecol. 2005;17: 135-142.
26. Swamy GK, Østbye T, Skjrven R. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA. 2008;12: 1429-1436.
27. Kramer MS, Demissie K, Yang H, et al. The contribution of mild and moderate preterm birth to infant mortality. JAMA. 2000;284: 843-849.
28. Suri R, Altshuler L, Hellemann G, et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007;164: 1206-1213.
29. Grzeskowiak LE, Gilbert AL, Morrison JL. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 2012;32: 615-621.
30. Roca A, Garcia-Esteve LI, Imaz ML, et al. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose. J Affect Disord. 2011;135: 208-215.